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Key points 26 
Question: Does either negative pressure wound therapy or standard wound dressing result in less 27 
disability 12 months after sustaining an open fracture of the lower limb. 28 
 29 
Findings: In this randomized clinical trial that included 460 adults, there was no statistically 30 
significant difference in self-rated disability between negative pressure wound therapy or 31 
standard wound dressing at 12 months (45.5 vs 42.4 points out of a possible 100). 32 
 33 
Meaning:  Negative pressure wound therapy did not improve 12-month disability for 34 
patients with severe open fracture of the lower limb compared with standard wound 35 
dressing 36 
 37 
 38 
 39 
 40 
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 50 
ABSTRACT 51 
Importance 52 
Open fractures of the lower limb occur when a broken bone penetrates the skin. These are life-53 
changing injuries where wound healing complications are common.  54 
Objectives 55 
To assess the disability, rate of deep infection and quality of life in patients with severe open 56 
fracture of the lower limb treated with negative pressure wound therapy (NPWT) versus standard 57 
wound management after the first surgical debridement of the wound.  58 
Design, Setting and Participants 59 
Multi-center, randomized trial, embedded in the UK Major Trauma Network, recruiting 460 patients 60 
16 years with a severe open fracture of the lower limb from July 2012 through December 2015. 61 
Final outcome collected November 2016. Exclusions: presentation > 72 hours after injury; inability to 62 
complete questionnaires. 63 
Interventions 64 
NPWT (n=226) where an open cell solid foam or gauze was placed over the surface of the wound 65 
and connected to a suction pump which created a partial vacuum over the dressing vs standard 66 
dressings not involving negative pressure (n=234). 67 
Main outcomes and Measures 68 
Disability Rating Index (DRI); score 0 [no disability] to 100 [completely disabled] at 12 months was 69 
the primary outcome measure, with a minimal clinically important difference (MCID) of 8 points. 70 
Secondary outcomes were complications including deep infection, and quality of life (QOL; score 71 
ranged from 1 (best possible) to -0.59 (worst possible), MCID 0.08) collected at 3, 6, 9 and 12 72 
months. 73 
Results 74 
 4 
Among 460 patients who were randomized (mean age, 45.3 years; 74% men), 88% (374/427) of 75 
available study participants completed the trial. There was no statistically significant difference in 76 
the patients’ DRI at 12 months (mean score 45.5 (sd=28.0) in the NPWT group vs 42.4 (24.2) in the 77 
standard dressing group; mean difference of -3.9 (95%CI; -8.9 to 1.2; p=0.13). There was no 78 
statistically significant difference in the number of deep surgical site infections (16 (7.1%) in the 79 
NPWT group vs 19 (8.1%) in the standard dressing group; difference 1.0% (95% CI; -4.2% to 6.3%; 80 
p=0.64). There was no statistically significant difference in QOL between groups; difference in EQ-5D 81 
0.02 (95% CI; -0.05 to 0.08), SF-12 PCS 0.5 (95% CI; -3.1 to 4.1) and SF-12 MCS -0.4 (95% CI; -2.2 to 82 
1.4). 83 
Conclusions and relevance 84 
Among patients with severe open fracture of the lower limb, use of negative pressure wound 85 
therapy compared with standard wound dressing did not improve self-rated disability at 12 months. 86 
The findings do not support this treatment for severe open fractures.  87 
 88 
Word count: 399 words 89 
Trial registration: Current Clinical Trials ISRCTN33756652 90 
  91 
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Background 92 
Fractures of the lower limb are common injuries in civilian and military populations.1,2 Most fractures 93 
are ‘closed’; the skin overlying the fracture is intact. However, if the fracture is 'open', the broken 94 
bone is exposed to contamination and the risk of healing complications is greatly increased.3 In 95 
severe, open fractures of the lower limb, infection rates up to 27% are reported, even in specialist 96 
trauma centres.4 The costs of treating wound complications is extremely high for both patients and 97 
healthcare systems.5 98 
The initial management of open fractures involves surgical debridement with excision of damaged 99 
tissue and contamination, and the administration of antibiotics. 6,7 The fracture is usually 100 
immobilized with fixation of the bone and a dressing is applied to the surface of the wound. 101 
Traditionally, a sealed, non-adhesive layer is applied to protect the open fracture from further 102 
contamination. Reassessment and further debridement of the wound typically performed 48-72 103 
hours later.  104 
Negative-pressure wound therapy (NPWT) is an alternative form of dressing. This device creates a 105 
vacuum using suction which removes blood and fluid that may collect in the wound. The vacuum 106 
may also encourage the formation of granulation (healing) tissue.4,8 However, NPWT dressings and 107 
the vacuum machines are considerably more expensive than traditional wound dressings. 108 
 Before this study, there was only one randomized clinical trial comparing standard wound dressing 109 
with NPWT for patients with open fractures of the lower limb.11 That trial suggested improved 110 
outcomes in patients treated with NPWT but included only 59 patients at a single trauma center. 111 
Despite the lack of strong evidence, clinical guidelines around the world incorporated the use of 112 
NPWT for open fracture wounds. 6,7,12 113 
The aim of this pragmatic, multicenter RCT was to compare standard wound dressings with negative 114 
pressure wound therapy for adults with an open fracture of the lower limb.  115 
 6 
Methods  116 
Study design and eligibility criteria 117 
The National Research Ethics Service approved the study, the approved protocol and statistical 118 
analysis plan are available as an online supplement. The trial was overseen by independent steering 119 
and data and safety monitoring committees. 120 
The trial took place in 24 major trauma hospitals representing the UK Major Trauma Network; in the 121 
UK, patients with serious injuries such as open fractures are transported directly to a specialist 122 
trauma center with joint orthopedic and plastic surgery facilities. Eligible patients were aged 16 123 
years or older and had a severe open fracture of the lower limb graded as Gustilo and Anderson II or 124 
III; type II is an open fracture with a laceration more than one centimeter long without extensive 125 
soft-tissue damage, flaps, or avulsions and type III either an open segmental fracture or an 126 
open fracture with extensive soft-tissue damage.14 Since surface NPWT can only be applied to 127 
wounds which are left open, the surgeons could only include the most severe injuries i.e. where is 128 
was not possible to safely suture the wound edges the end of the first surgical debridement.  129 
Patients had to present to the trial hospital within 72 hours of their injury, including those who were 130 
transferred from other hospitals. Patients were excluded if they had known contra-indications to 131 
anesthesia or were deemed unable to adhere to trial procedures or complete questionnaires, for 132 
example those with a pre-existing diagnosis of dementia.  For patients with acute confusional states 133 
or temporary impairment of consciousness, we approached a Consultee to provide agreement on 134 
behalf of the patient, as per the UK Mental Capacity Act 2005. All participants randomized under this 135 
provision, were subsequently approached for consent once capacity was restored, with the option 136 
to continue or discontinue involvement in the trial.  For this reason, we anticipated higher levels of 137 
post-randomization withdrawal than might be expected in most clinical trials.  138 
RANDOMISATION AND MASKING 139 
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A computer-generated randomization algorithm was created by the trial statistician and delivered by 140 
an accredited Clinical Trials Unit to ensure that the allocation sequence was concealed. The 141 
individual patient was allocated treatment on a 1:1 basis, stratified by trial center and Gustilo and 142 
Anderson grade; the Gustilo and Anderson grade. When a patient entered the trial, non-identifiable 143 
details were logged on the secure, encrypted, web-based system.  144 
Participants were assigned to their treatment allocation intraoperatively at the end of initial surgery, 145 
but before any wound dressing was applied.  146 
It was not possible to blind trial participants to treatment allocation as wound dressings were clearly 147 
visible. In addition, the treating surgeons could not be blind to the intervention, but the surgical and 148 
healthcare team were not involved in any trial assessments. Wound photographs taken at six weeks 149 
and standard radiographs were used to look for signs of delayed wound healing and non-union of 150 
the bone respectively. These were reviewed by independent clinicians who were blind to the 151 
treatment allocation.  152 
INTERVENTIONS 153 
At presentation, all patients were listed for the next available trauma operating list.  In the operating 154 
theatre, all patients received a general or regional anesthetic. The wound associated with the 155 
fracture was surgically debrided and the fracture immobilized with either internal (under the skin) or 156 
external fixation. At the end of the initial operation, if the wound could not be closed primarily i.e. 157 
direct suture of the wound edges was not possible, the patient was randomized to either standard 158 
dressings or NPWT. All other elements of postoperative care remained the same for all patients. 159 
Standard Dressing Group. All hospitals used a sterile dressing sealed from external contamination. 160 
However, the details of the materials used were left to the discretion of the treating healthcare 161 
team as per routine care at their center.  Details of each dressing applied in the trial were recorded 162 
and classified according to British National Formulary (BNF) classification. 163 
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NPWT group. The NPWT dressing used an ‘open-cell’ solid foam or gauze laid onto the wound 164 
followed by an adherent, sealed dressing. A sealed tube was connected from the dressing to a 165 
suction pump which created a partial vacuum over the wound. The basic features of the NPWT are 166 
universal, but the exact details of the dressing and pressure (mmHg) were left to the discretion of 167 
the treating healthcare team. Details of the NPWT were recorded in trial documentation. 168 
Patients with an open fracture of the lower limb that could not be closed primarily, had a second 169 
operation at 48-72 hours, where a further wound assessment and debridement was performed and 170 
the wound closed either primarily with sutures or by soft-tissue reconstruction as necessary. 171 
DATA COLLECTION AND OUTCOME MEASURES 172 
The primary outcome was the patient-reported Disability Rating Index (DRI) at 12 months after 173 
randomisation.15 The DRI provides a 100-point score, where zero represents normal function and 174 
100 complete disability, with a minimum clinically important difference of 8 points.  175 
Secondary outcomes were health-related quality of life using EuroQol (EQ-5D-3L) 16,17 and Short form 176 
12 (SF-12) 18,19 deep surgical site infection (SSI) at 30 days as per CDC definition20 and other 177 
complications. EQ-5D-3L responses were converted into an overall utility score 17, that ranged from 1 178 
(best possible) to -0.59 (worst possible), where zero represents the quality of life associated with 179 
death; the minimum clinically important difference is 0.08 points. Physical and mental health 180 
Composite Scores (PCS and MCS) were computed from SF-12 responses 21; these scores range from 0 181 
to 100, where a 0 score indicates the lowest level of health. Infection outcomes and complications 182 
were extracted from the patients’ medical records by independent research staff in each trial center. 183 
Wound photographs and radiographs were reviewed independently and blind to treatment 184 
allocation.  185 
Deep infection following an open fracture is a key driver of subsequent disability. However, a deep 186 
infection which is treated early and definitively may resolve completely with no disability. Similarly, 187 
wounds which are not infected may still heal with excess scar-tissue or require extensive tissue 188 
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grafts which can lead to reduced mobility and chronic pain. Therefore, the DRI was considered to be 189 
more important as a primary outcome measure than the rate of deep infection or size of the wound 190 
per se. Patient-reported outcomes (DRI, EQ-5D-3L, SF-12) and self-reported complications were 191 
collected by questionnaire. Pre-injury baseline scores were collected retrospectively at the time of 192 
consent and again by postal questionnaire at three, six, nine, and twelve months. 193 
 194 
STATISTICAL ANALYSIS 195 
A minimum clinically important difference for the Disability Rating Index of 8 points was selected to 196 
power the study;13 for an individual patient, at the lower level this represents the ability to climb 197 
stairs or run, with ‘some difficulty’ versus, at the higher level with ‘great difficulty’ and at a 198 
population level, eight points represents the difference between a ‘healthy patient’ (score=1 199 
points)and a ‘patient with a minor disability’(score=9 points). The standard deviation (SD) of the DRI 200 
used in the sample size calculation was 25 points. Allowing a margin of 10% loss during follow-up, 201 
including the small number of patients who die in the first year following their injury, gave a total 202 
sample size of 460 patients. Therefore, 230 patients consented to each intervention group would 203 
provide 90% power to detect a difference of eight points in DRI at 12 months at the 5% significance 204 
level. 205 
When calculating summary statistics for assessing treatment efficacy, NPWT data were subtracted 206 
from control group data; such that a positive difference indicated that a score or outcome measure 207 
was larger in the control group. We investigated differences in the primary outcome measure, the 208 
DRI score at one year after injury, between the two treatment groups on an intention-to-treat basis. 209 
Early and mid-term disability was assessed and reported at three, six and nine months. A secondary 210 
per-treatment analysis was also performed. Mixed-effects regression analysis, with recruiting center 211 
as a random effect, and fixed terms to adjust for age group, sex, baseline pre-injury score and 212 
Gustilo and Anderson grade was used to test for treatment group differences using complete case 213 
 10 
data. Secondary endpoints were not adjusted for multiple comparisons, and should be interpreted 214 
as exploratory. In a post hoc sensitivity analysis for the primary outcome, missing data were imputed 215 
using the chained equation methodology 22 and models fitted to give a pooled estimate of the 216 
treatment effect. 217 
 All tests were two-sided and significance was assessed at the 5% level. Analyses of primary and 218 
secondary outcomes used complete-case data and all analyses were implemented in R version 3.3.0 219 
23, using packages base, graphics, mice, lme4 and nlme (see https://cran.r-project.org/).   220 
221 
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Results 222 
A total of 625 patients were randomized  between July 2012 and December 2015. Some patients 223 
who did not have mental capacity before surgery, were unable or not willing to provide informed 224 
consent after randomization. The majority of the 165 patients who did not provide consent were 225 
found to be ineligible after randomization; for example, due to primary closure of the wound or 226 
permanent cognitive impairment which could not be predicted before surgery/randomization. Only 227 
29 potentially eligible patients declined to participate in the trial; 14 in the NPWT group and 15 in 228 
the standard dressing group (Figure 1).  229 
A total of 460 patients consented to take part in the WOLLF trial: 85% were grade III injuries and 82% 230 
involved the tibia. The characteristics of the two groups were well balanced after randomization 231 
(Table 1). 232 
**Figure 1** 233 
**Table 1** 234 
On an intention-to-treat basis, there was no significant difference in the DRI at 12 months  between 235 
those patients treated with NPWT versus those treated with standard wound dressings (Figure 2). 236 
The mean DRI in the NPWT group was 45.5 versus 42.4 in the standard dressing group, giving a 237 
difference of -3.9 (95%CI; -8.9 to 1.2) in favor of standard dressings, p-value=0.13; from adjusted 238 
mixed-effect regression analysis (Table 2). Therefore, the results of this trial are consistent with a -239 
8.9 worse disability rating attributable to the use of NPWT which, based on the minimal clinically 240 
important difference, would be clinically important but also ranging to a non-clinically important 241 
benefit of these dressings of 1.2 points on the DRI scale. Similarly, there was no significant difference 242 
in disability rating at three months, six months or nine months (Figure 2). 243 
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The secondary per-protocol (per treatment) analysis of the DRI did not significantly differ from the 244 
primary intention-to-treat analysis; the difference between groups being -4.0 (95% CI; -9.1 to 1.0) in 245 
favour of the standard dressings (p-value 0.12).  246 
**Table 2** 247 
Secondary exploratory analysis showed that there was no significant difference in the health-related 248 
quality of life scores between the treatment groups at any point in the 12 months following the 249 
injury. The mean SF-12 Physical Component Score at 12 months in the NPWT group was 32.2 (17.4) 250 
versus 32.7 (15.5) in the standard dressing group, giving an adjusted difference of 0.4 (-3.0 to 3.8) in 251 
favor of standard dressings (p-value=0.82; from adjusted mixed-effect regression analysis). The 252 
mean EQ-5D score in the NPWT group was 0.55 (0.33) versus 0.56 (0.32) in the standard dressing 253 
group, giving a difference of 0.01 (-0.06 to 0.07) in favor of standard dressing (p-value=0.82). 254 
There was no significant difference in the number of deep surgical site infections between the 255 
treatment groups (Table 3). In total 35 of the 460 participants (7.6%) had a deep SSI at 30 days; 16 256 
(7.1%) in the NPWT treatment group and 19 (8.1%) in the standard dressing group, giving an 257 
estimated odds ratio 0.85 (95% CI; 0.42 to 1.70) and percentage difference in rates 1.0% (95% CI; -258 
4.2% to 6.3%) in favor of NPWT (p-value=0.64 from adjusted mixed-effect logistic regression 259 
analysis). There was no significant difference in the proportion of wounds found to be fully healed 260 
on the six-week photographs; 52.0% (91/175) in the NPWT group and 51.7% (93/180) in the 261 
standard dressing group, giving an odds ratio of 1.0 (95%CI; 0.6 to 1.6, p-value=0.99) and difference 262 
in rates -0.3% (95% CI; -11.1% to 10.4%). There was no significant difference in the proportion of 263 
patients with complete bone union on the radiographs at 12-months; 69.6% (112/161) in the NPWT 264 
group and 71.9% (110/153) in the standard dressing group, giving an odds ratio of 1.1 (95%CI;0.7 to 265 
1.9, p-value=0.68) and difference in rates 2.3% (95% CI; -8.4% to 13.0%). 266 
The primary outcome data were 88% complete (374 of 427 available study participants provided 267 
final outcome data) and there was no evidence for non-random patterns of missingness. Imputing 268 
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missing data gave pooled estimates of the treatment effect for DRI at 12 months as - 4.5 (95% CI; -269 
9.3 to 0.4), with the percentage of the variability attributable to the uncertainty caused by the 270 
missing data estimated at 12.8%. 271 
**Table 3** 272 
Discussion 273 
This multi-center trial of patients with severe open fractures of the lower limb, found no significant 274 
difference in the Disability Rating Index between those patients treated with NPWT versus those 275 
treated with standard wound dressings at 12 months post-injury. There was no significant difference 276 
in the rate of deep surgical site infection, or other healing complications. Nor was there a significant 277 
difference in health-related quality of life at any point in the first 12 months after the injury.  278 
Before this trial,a review of the literature 24 showed only one RCT comparing standard wound 279 
dressing with NPWT for the initial management of patients with severe open fractures of the lower 280 
limb. Stannard et al 11 demonstrated a difference in health-related quality of life and a reduction in 281 
the rate of deep wound infection in patients treated with NPWT compared with control (5.4% versus 282 
20%; RR 0.199, 95% CI 0.05, 0.87).  However, this was a small trial (59 patients, 63 fractures), and 283 
there were only 7 deep infections in the control group and 2 in the NPWT group. It is possible that 284 
this difference in the rate of deep infection was due to systematic differences in the patients and/or 285 
treatment pathway in a single center in the US, compared with the WOLLF trial which took place in 286 
the much broader setting of 24 major trauma centers. However, given the relatively small number of 287 
cases in the Stannard et al trial, it is possible that the result represents a lack of precision in the 288 
estimate of the incidence of deep infection. A trial published in 2016 also comparing NPWT with 289 
standard dressings in the context of open fractures. This study took place in Pakistan and used 290 
negative pressure dressings over a prolonged period of time (weeks) to reduce the size of the 291 
wound.25 This is a very different use of NPWT than advocated by current guidance for the 292 
management of open fractures, where early definitive wound closure - within 72 hours - is 293 
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recommended.6,7 Therefore, it is not clear whether the results of that trial are pertinent to other 294 
healthcare systems. 295 
Limitations 296 
This study has several limitations. Firstly, patients with an open fracture of the lower limb have 297 
usually experienced severe trauma and present to hospital with variable states of consciousness and 298 
cognition. For emergency interventions, it was anticipated that some patients who were randomized 299 
would subsequently found not to be eligible or not able to provide informed consent; for example 300 
patients who had significant head injury or who died of their injuries in the early post-operative 301 
period. Some patients were also found to be ineligible after randomization due to the surgeon 302 
deciding that the wound could be closed by direct suturing, which may reflect the difficulties of 303 
classifying these injuries at the time of the initial debridement of the wound; only patients where 304 
the surgeon felt that the wound had to be left open were included in the trial 26.  However, 460 of 305 
the 485 (95%) patients who were randomized and eligible for the trial agreed to participate, 306 
suggesting that participants were representative of the overall population with severe open 307 
fractures of the lower limb. Second, after randomization some patients crossed over from one 308 
treatment group to another. However, 95% percent of patients received the treatment to which 309 
they were allocated. Third, there was loss to follow-up, with study completion by only 88% of the 310 
original participants. However, multiple imputation analysis resulted in consistent findings. Finally, 311 
although patients were only eligible to enter the study if they presented to the treating hospital 312 
within 72 hours of their injury, we were not able to adjust for the exact time of the open fracture 313 
which is a possible confounder in the analysis.  314 
Conclusion 315 
Among patients with severe open fracture of the lower limb, use of negative pressure wound 316 
therapy compared with standard wound dressing did not improve self-rated disability at 12 months.  317 
 318 
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Figure 2  430 
Temporal trends in main study outcomes. Disability Rating Index (DRI), the primary outcome 431 
(Panel A), EQ-5D quality of life (Panel B) and SF-12 physical component score (PCS) and 432 
mental component score (MCS) (Panel C). Shown are means, with 95% confidence 433 
intervals, at each study follow-up time point (3, 6, 9 and 12 months) and at baseline (Base). 434 
Pre-injury assessments were made retrospectively by all study participants and immediately 435 
post-injury for EQ-5D. Minimum clinically important differences (MCID) are shown for DRI 436 
and EQ-5D. 437 
  438 
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Table 1. Characteristics of the Study Participants 
 
Characteristic NPWT 
(n = 226) 
Standard 
(n = 234) 
 
Age (years);  mean (sd) 46.1 (19.9) 44.5 (19.0) 
 median (IQR) 42 (29 – 61) 44 (26 – 57) 
Height (meters); mean (sd) 1.74 (0.12) 1.72 (0.16) 
Weight (kg); mean (sd) 80.9 (16.8) 80.9 (19.4) 
Male sex; n (%) 178 (78.8) 164 (70.1) 
Diabetes; n (%) 14 (6.2) 13 (5.6) 
Smoker; n (%) 70 (31.0) 79 (33.8) 
 no. per day; mean (sd) 15.4 (10.9) 15.3 (10.4) 
years; mean (sd) 17.6 (12.4) 17.4 (12.0) 
Employment; n (%) 
 Employed 147 (65.0) 160 (68.4) 
 Retired or Inactive 44 (19.5) 44 (18.8) 
 Unemployed 28 (12.4) 25 (10.7) 
 Unknown 7 (3.1) 5 (2.1) 
Mechanism of injury; n (%) 
 Road traffic accident 125 (55.3) 139 (59.4) 
 Low energy fall 34 (15.0) 39 (16.7) 
 High energy fall 34 (15.0) 25 (10.7) 
 Crush injury 17 (7.5) 19 (8.1) 
 Other 13 (5.8) 9 (3.8) 
 Contact sports injury 3 (1.3) 1 (0.4) 
 Unknown 0 (0.0) 2 (0.9) 
Injuries associated with the open fracture†; n (%) 58 (25.7) 76 (32.5) 
 Upper limb 17 (7.5) 32 (13.7) 
Chest 24 (10.6) 22 (9.4) 
Spine 21 (9.3) 22 (9.4) 
 22 
Head 14 (6.2) 11 (4.7) 
Pelvis 8 (3.5) 15 (6.4) 
Ipsilateral lower limb 6 (2.7) 16 (6.8) 
Contralateral lower limb 4 (1.8) 14 (6.0) 
Abdomen 3 (1.3) 12 (5.1) 
Gustilo & Anderson grade; n (%)   
 Grade 2 34 (15.0) 30 (12.8) 
Grade 3 171 (75.7) 180 (76.9) 
Grade 3 + VI 21 (9.3) 24 (10.3) 
Fracture fixation; n (%)   
 External fixator-half-pin 107 (47.3) 111 (47.4) 
 Nail 49 (21.7) 56 (23.9) 
 Plate and screws 38 (16.8) 32 (13.7) 
 Other 21 (9.3) 21 (9.0) 
 External fixator-fine-wire 3 (1.3) 11 (4.7) 
 Wires/tension band wires 7 (3.1) 3 (1.3) 
 Unknown 1 (0.4) 0 (0.0) 
IQR = interquartile range; sd = standard deviation;  
† Some study participants had multiple injuries associated with the open fracture 
 440 
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Table 2. Primary and secondary outcomes  
 NPWT Standard Difference (95% CI) P value for adjusted analysis 
 Mean (sd) n Mean (sd) n Raw† Adjusted‡  
Primary outcome 
DRI (12 m)  45.5 (28.0) 179 42.4 (24.2) 195 -3.1 (-8.5 - 2.2) -3.9 (-8.9 - 1.2) 0.13 
Secondary outcomes 
Disability scores over time 
DRI (3 m) 64.3 (22.3) 166 65.6 (20.1) 188 1.3 (-3.1 - 5.8) 0.7 (-3.7 - 5.0) 0.76 
DRI (6 m) 53.2 (23.8) 154 50.3 (24.1) 175 -2.8 (-8.0 - 2.4) -3.5 (-8.4 - 1.5) 0.17 
DRI (9 m) 49.2 (25.9) 153 45.4 (25.2) 161 -3.8 (-9.5 - 1.9) -4.4 (-10.0 - 1.3) 0.13 
Quality of life 
EQ-5D (12 m) 0.55 (0.33) 172 0.56 (0.32) 192 0.02 (-0.05 - 0.08) 0.01 (-0.06 - 0.07) 0.82 
SF-12 PCS (12 m) 32.2 (17.4) 154 32.7 (15.5) 175 0.5 (-3.1 - 4.1) 0.4 (-3.0 - 3.8) 0.82 
SF-12 MCS (12 m) 44.7 (8.4) 154 44.3 (8.2) 175 -0.4 (-2.2 - 1.4) -0.2 (-2.1 - 1.6) 0.80 
† Mean of Standard group minus mean of NPWT (Negative Pressure Wound Therapy) group; for DRI a negative value is in favor of the Standard 
treatment, as a lower score indicates less disability 
‡ Mixed effects regression based on a complete case analysis with, treatment group, age group, gender, baseline pre-injury score and wound grade as 
covariates (fixed effects) and recruiting center as a random effect; p-values are from analysis of variance (ANOVA) F-test  
sd = standard deviation 
Disability Rating Index (DRI) is assessed on a 100-point score scale, where zero represents normal function and 100 complete disability, with a minimum 
clinically important difference of 8 points 
 24 
EuroQol EQ-5D-3L (EQ-5D) is a measure of health-related quality of life, in the range -0.59 (worst possible state)  to 1 (perfect health), anchored at 0 
(death), with a minimum clinically important difference 0.08 points 
SF-12 Physical and Mental health Composite Scores (PCS and MCS) are computed from the short form health survey and range from 0 to 100, where a 0 
score indicates the lowest level of health 
 443 
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Table 3: Post-operative complications reported as secondary outcomes during 12 months follow-up 
 
Table 3. Postoperative complications 
Complication NPWT 
(n = 226) 
Standard 
(n = 234) 
Difference (%) Odds ratio‡ P value‡ 
Wound complications at 30 days 
Red and inflamed; n (%) 13 (5.8) 19 (8.1) 2.4 (-2.7 - 7.4) 0.64 (0.28 - 1.42) 0.27 
Swollen; n (%) 38 (16.8) 49 (20.9) 4.1 (-3.4 - 11.7) 0.70 (0.42 - 1.16) 0.15 
Painful/tender; n (%) 35 (15.5) 33 (14.1) -1.4 (-8.3 - 5.5) 1.01 (0.58 - 1.77) 0.99 
Fluid leaking; n (%) 28 (12.4) 27 (11.5) -0.9 (-7.2 - 5.5) 1.01 (0.55 - 1.86) 0.99 
Fluid (pus) cloudy; n (%) 11 (4.9) 10 (4.3) -0.6 (-4.8 - 3.7) 1.21 (0.43 - 3.46) 0.81 
Gaping open; n (%) 6 (2.7) 4 (1.7) -0.9 (-4.1 - 2.2) 1.48 (0.34 - 7.22) 0.75 
Surgeon opened; n (%) 2 (0.9) 0 (0.0) - - - 
Fever > 38oC; n (%) 0 (0.0) 0 (0.0) - - - 
Abscess/infection; n (%) 3 (1.3) 5 (2.1) 0.8 (-2.0 - 3.6) 0.57 (0.09 - 2.95) 0.49 
Deep surgical site infection at 30 days 
Deep SSI†; n (%) 16 (7.1) 19 (8.1) 1.0 (-4.2 – 6.3) 0.85 (0.42 -1.70) 0.64 
Other postoperative complications related to the index wound / injury reported during follow-up 
Soft Tissue^; n (%) 20 (8.8) 17 (7.3) -1.6 (-7.0 - 3.8) 1.24 (0.60 - 2.59) 0.61 
Neurovascular; n (%) 5 (2.2) 8 (3.4) 1.2 (-2.2 - 4.7) 0.64 (0.16 - 2.26) 0.58 
Persistent pain; n (%) 8 (3.5) 11 (4.7) 1.2 (-2.9 - 5.2) 0.74 (0.25 - 2.08) 0.64 
DVT/PE^^; n (%) 6 (2.7) 4 (1.7) -0.9 (-4.1 - 2.2) 1.57 (0.37 - 7.65) 0.54 
Further surgery related to the open fracture reported during follow-up 
Revision fixation; n (%) 18 (8.0) 15 (6.4) -1.6 (-6.7 - 3.6) 1.26 (0.58 - 2.77) 0.59 
Wound management; n (%) 19 (8.4) 21 (9.0) 0.6 (-5.0 - 6.1) 0.93 (0.46 - 1.88) 0.87 
Bone graft; n (%) 10 (4.4) 18 (7.7) 3.3 (-1.5 – 8.0) 0.56 (0.22 - 1.31) 0.17 
Amputation; n (%) 4 (1.8) 6 (2.6) 0.8 (-2.3 - 3.9) 0.69 (0.14 - 2.93) 0.75 
‡ Unless stated otherwise, odds ratio, 95% confidence interval and p-value from Fisher’s exact test; a value > 
1 indicates a greater risk in the NPWT group; where testing was not possible or sensible, then these are marked 
as ‘-’ 
† Deep SSI was recorded according to CDC criteria: involvement of deep tissues with purulent drainage from 
the incision, or spontaneous dehiscence or incision deliberately opened by a surgeon and there was fever or 
localized pain or tenderness, or confirmation of abscess, or deep SSI diagnosed by a surgeon/attending 
physician.  
^ Complications that are not related to the bone and not included under wound infection, for example 
problems causes by scar tissue or tendon irritation. 
^^ Deep vein thrombosis/Pulmonary Embolism 
 
